{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:10:04Z","timestamp":1749514204970,"version":"3.41.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["CA21116"],"award-info":[{"award-number":["CA21116"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.semcancer.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:10:23Z","timestamp":1746547823000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2\/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against."],"prefix":"10.1016","volume":"113","author":[{"given":"Julie","family":"Earl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agapi","family":"Kataki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Canzian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eithne","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1865-3195","authenticated-orcid":false,"given":"William","family":"Greenhalf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2025.05.001_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2025.05.001_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2025.05.001_bib3","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2025.05.001_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005720","article-title":"A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer","volume":"4","author":"Keane","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.semcancer.2025.05.001_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","article-title":"Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants","volume":"8","author":"Momozawa","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2019-319352","article-title":"Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium","volume":"69","author":"Goggins","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.05.001_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2024.1930","article-title":"Pancreatic cancer surveillance and survival of high-risk individuals","author":"Blackford","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11605-017-3421-2","article-title":"Asymptomatic pancreatic cancer: does incidental detection impact long-term outcomes?","volume":"21","author":"Takeda","year":"2017","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.semcancer.2025.05.001_bib9","article-title":"Patient characteristics associated with definitive diagnosis of metastatic pancreatic cancer in those initially diagnosed with cancer of unknown primary","author":"White","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.semcancer.2025.05.001_bib10","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1038\/s41598-022-08083-6","article-title":"Clinical features and prognostic impact of asymptomatic pancreatic cancer","volume":"12","author":"Takikawa","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2025.05.001_bib11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gutjnl-2020-323611","article-title":"Long-term yield of pancreatic cancer surveillance in high-risk individuals","volume":"71","author":"Overbeek","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.05.001_bib12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/j.gastro.2023.02.032","article-title":"Surveillance for pancreatic cancer in high-risk individuals leads to improved outcomes: a propensity score-matched analysis","volume":"164","author":"Klatte","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2025.05.001_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10689-017-0057-z","article-title":"Development of a high risk pancreatic screening clinic using 3.0 T MRI","volume":"17","author":"Barnes","year":"2018","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.semcancer.2025.05.001_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PPO.0000000000000290","article-title":"Diagnosis and detection of pancreatic cancer","volume":"23","author":"Chu","year":"2017","journal-title":"Cancer J."},{"key":"10.1016\/j.semcancer.2025.05.001_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2214\/AJR.22.27859","article-title":"Standardization of MRI screening and reporting in individuals with elevated risk of pancreatic ductal adenocarcinoma: consensus statement of the PRECEDE consortium","volume":"219","author":"Huang","year":"2022","journal-title":"Ajr"},{"key":"10.1016\/j.semcancer.2025.05.001_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2015-310162","article-title":"Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis","volume":"66","author":"Crippa","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2025.05.001_bib17","article-title":"Identification of cystic lesions by secondary screening of familial pancreatic cancer (FPC) kindreds is not associated with the stratified risk of cancer","author":"Sheel","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib18","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN guidelines(R) insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"key":"10.1016\/j.semcancer.2025.05.001_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41467-017-00388-9","article-title":"BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers","volume":"8","author":"Maxwell","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2025.05.001_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2010.10.015","article-title":"Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer","volume":"18","author":"Skoulidis","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2025.05.001_bib21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1200\/JCO.21.02112","article-title":"Cancer risks associated with BRCA1 and BRCA2 pathogenic variants","volume":"40","author":"Li","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib22","doi-asserted-by":"crossref","unstructured":"Chen J., Bae E., Zhang L., Hughes K., Parmigiani G., Braun D., et al. Penetrance of Breast and Ovarian Cancer in Women Who Carry a BRCA1\/2 Mutation and Do Not Use Risk-Reducing Salpingo-Oophorectomy: An Updated Meta-Analysis. JNCI Cancer Spectr 2020;4:pkaa029.","DOI":"10.1093\/jncics\/pkaa029"},{"key":"10.1016\/j.semcancer.2025.05.001_bib23","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/cncr.28662","article-title":"BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts","volume":"120","author":"Lucas","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2025.05.001_bib24","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.semcancer.2025.05.001_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cncr.26191","article-title":"Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer","volume":"118","author":"Stadler","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2025.05.001_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3748\/wjg.v27.i17.1943","article-title":"BRCA mutated pancreatic cancer: a change is coming","volume":"27","author":"Rosen","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2025.05.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100881","article-title":"A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing","volume":"8","author":"Paiella","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.semcancer.2025.05.001_bib29","first-page":"15","article-title":"Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018","author":"Samaan","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2025.05.001_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cgh.2019.05.059","article-title":"Racial disparities and trends in pancreatic cancer incidence and mortality in the United States","volume":"18","author":"Tavakkoli","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"key":"10.1016\/j.semcancer.2025.05.001_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2018.00624","article-title":"A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases","volume":"9","author":"Oliveri","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.semcancer.2025.05.001_bib33","article-title":"Genetic testing for successful cancer treatment","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.semcancer.2025.05.001_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020","volume":"18","author":"Daly","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"key":"10.1016\/j.semcancer.2025.05.001_bib35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.gastro.2020.03.088","article-title":"AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review","volume":"159","author":"Aslanian","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2025.05.001_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.gie.2021.12.001","article-title":"ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations","volume":"95","author":"Sawhney","year":"2022","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.semcancer.2025.05.001_bib37","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1053\/j.gastro.2021.08.036","article-title":"Recommendations for a more organized and effective approach to the early detection of pancreatic cancer from the PRECEDE (Pancreatic Cancer Early Detection) consortium","volume":"161","author":"Gonda","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2025.05.001_bib38","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.7150\/jca.20750","article-title":"Pancreatic cancer in lynch syndrome patients","volume":"8","author":"Bujanda","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2025.05.001_bib39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-0004.2009.01352.x","article-title":"Clinical and genetic analysis of 18 pancreatic carcinoma\/melanoma-prone families","volume":"77","author":"Bartsch","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.semcancer.2025.05.001_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jnci\/95.3.214","article-title":"BRCA2 germline mutations in familial pancreatic carcinoma","volume":"95","author":"Hahn","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2025.05.001_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1399-0004.2010.01425.x","article-title":"PALB2 mutations in European familial pancreatic cancer families","volume":"78","author":"Slater","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.semcancer.2025.05.001_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2025.05.001_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jmedgenet-2020-106961","article-title":"Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction","volume":"58","author":"Galeotti","year":"2021","journal-title":"J. Med Genet"},{"key":"10.1016\/j.semcancer.2025.05.001_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2020.08.003","article-title":"Germline genetic variability in pancreatic cancer risk and prognosis","volume":"79","author":"Gentiluomo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104020","article-title":"The PANcreatic Disease ReseArch (PANDoRA) consortium: ten years' experience of association studies to understand the genetic architecture of pancreatic cancer","volume":"186","author":"Campa","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2025.05.001_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.dld.2012.09.014","article-title":"Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium","volume":"45","author":"Campa","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2025.05.001_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00439-019-02034-4","article-title":"Missing heritability of complex diseases: case solved?","volume":"139","author":"Genin","year":"2020","journal-title":"Hum. Genet"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:51:02Z","timestamp":1749513062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X25000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S1044579X25000586"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.05.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"type":"print","value":"1044-579X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2\/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against.","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}